An overview on colonic drug delivery system

International Journal of Pharmaceutical Sciences Review and Research

Volumn 6, Issue 2, 2011, Pages 197-204

  Rajguru, Vishal V ^a   Gaikwad, Preeti D ^a   Bankar, Vidyadhar H ^a   Pawar, Sunil P ^a  

^a PSGVPM's College of Pharmacy   (India)

Author keywords

Approaches; Colon drug delivery; Polymers; Recent techniques

Indexed keywords

EUDRAGIT; INSULIN; VASOPRESSIN;

COLON FLORA; DRUG BIOAVAILABILITY; DRUG COATING; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG TARGETING; FUNCTIONAL ANATOMY; HUMAN; INTESTINE TRANSIT TIME; NONHUMAN; REVIEW; STOMACH PH; TABLET DISINTEGRATION;

EID: 79952057103     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Chourasia MK, Jain SK. Design and development of multiparticulate system for targeted drug delivery to colon. J Drug Delivery Sys, 2004; 11: 201-7
2. Banker GS. Modern Pharmaceutics. 4th edition, Marcel Dekker, New York, 2002, 527-584.
3. Abdul B, John B. Perspectives on colonic drug delivery. Business Briefing, Pharmatech, 2003, 185-190.
4. Bajpai SK, Bajpai M, Dengree R. Chemically treated gelatin capsules for colon targeted drug delivery: a novel approach. J Applied Poly Sci, 2003, 89, 2277-2282.
5. Edith M. Encyclopedia of controlled drug delivery. John Wiley and sons, Inc. New york, 2003, 698-726.
6. Sarasija S, Hota A. Colon specific drug delivery systems. Indian J Pharm Sci, 2000, 62: 1-8.
7. Kushwaha P, Fareed S, Nanda S. Colonic drug delivery: An overview. Intern J Pharma Res Develop, 2010, 2(4), 1-10
8. Ratna V, Prabhakaran L, Puroshottam M. Colon targeted drug delivery system An overview. Targeted Drug Delivery System, 2010, 8(2).
9. Ratna V, Prabhakaran L, Puroshottam M. Colon targeted drug delivery system - An overview. Targeted Drug Delivery System, 2010, 8(2).
10. Ratna V, Prabhakaran L, Puroshottam M. Colon targeted drug delivery system - An overview. Targeted Drug Delivery System, 2010, 8(2).
11. Ratna V, Prabhakaran L, Puroshottam M. Colon targeted drug delivery system - An overview. Targeted Drug Delivery System, 2010, 8(2).
12. Anil K, Philip B. Colon targeted drug delivery systems: A review on primary and novel approaches. Oman Med J, 25(2), April 2010, 70-78
13. Sangalli ME, Maroni A, Zema L, Busetti C, Giordano F, Gazzanica A. In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J Controlled Release, 73, 103-110.
14. Lorenzo-Lamosa M., Remuñán-López C., Vila-Jato J. and Alonso M. 1998. Design of microencapsulated chitosan microspheres for colonic drug delivery. J Controlled Release, 52, 109-118.
15. Stevens H, Wilson C, Welling P, Bakhshaee M, Binns J, Perkins A, Frier M, Blackshaw E, Frame M, Nichols D, Humphrey M, Wicks S. Evaluation of Pulsincap™ to provide regional delivery of dofetilide to the human GI tract. Intern J Pharm, 236, 2001, 27-34.
16. Wilding I, Coupe A, Davis S. 1991. The role of gammascintigraphy in oral drug delivery. Adv. Drug Del. Rev. 7, 2001, 87-117.
17. Pirjo N. Development of multiple-unit oral formulations for colon specific drug delivery using enteric polymers and organic acids as Excipients. Division of Biopharmaceutics and Pharmacokinetics Dept of Pharmacy University of Helsinki, Finland, 2003. 1-44.
18. Marvola M, Nykänen P, Rautio S, Isonen N, Autere A.M. Enteric polymers as binders and coating materials in multipleunit site specific drug delivery systems. Eur J Pharm Sci, 1999, 259-267.
19. Nykänen P, Krogars K, Säkkinen M, Heinämäki J, JFrjenson H, Veski P, Marvola M. Organic acids as excipients in matrix granules for colon specific drug delivery. Intern J Pharm, 1999, 184, 251-261.
20. Nykänen P, Lempää S, Aaltonen MLJ. Frjenson H, Veski P, Marvola M. Citric acid as excipient in multiple-unit enteric coated tablets for targeting drugs on the colon. Intern J Pharm, 2001, 229, 155-162.
21. Nykänen P, Sten T, Frjenson H, Veski P, Marvola M. Citric acid as a pH regulating additive in granules and in the tablet matrix in enteric coated formulations for colon specific drug delivery. 2003.
22. Kumar M, Ali A, Kaldhone P, Shirode A, Kadam VJ. Report on pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Res, 2010, 3(3), 470-473.
23. Aurora J. Colonic drug delivery challenges and opportunities - An overview. Eur Gastroenterology Review 2006; 1: 1-4.
24. El-Kamel AH. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment. Intern J Pharm, 2008; 358: 248-255.
25. Yang L. Colon specific drug delivery: new approaches and in vitro/in vivo evaluation. Intern J Pharm, 2002; 235: 1-15.
26. Gupta VK. A novel pH- and time based multiunit potential colonic drug delivery system development. Intern J Pharm, 2001; 213: 83-91
27. Rathod S, Ram A. Targeted pulsatile drug delivery- A review. Pharmainfo.net 2007; 5(2)
28. Roy P, Shahiwala A. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. J Control Release 2009; 134: 74-80.
29. Asghar LFA, Chandran S. Multiparticulate formulation approach to colon specific drug delivery: current perspectives. J Pharm Pharm Sci, 2006; 9(3): 327-338.
30. Sinha VR, Kumria R. Microbially triggered drug delivery to the colon. Eur J Pharma sci, 2003; 18: 3-18.
31. Brown S. New concepts in colonic drug targeting formulation for delivery, October 2009.
32. Ibekwe VC, Khela MK, Evans DF, Basit AW. A new concept in colonic drug targeting: A combined pHresponsive and bacterially triggered drug delivery technology. Aliment Pharmacol Ther 28, 911-916, 2008.
33. McConnell EL, Fadda HM, Basit AW. Gut instincts: explorations in intestinal physiology and drug delivery. Intern J Pharm 364, 213-226, 2008.
34. http://www.patentstorm.com